Is this you? Create Your Porfile
Avatar

Hakan Kaya

University of Washington

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Hakan Kaya is active.

Explore More

Publication

Featured researches published by Hakan Kaya.

International Journal of Hematology | 2012

Impact of age, race and decade of treatment on overall survival in a critical population analysis of 40,000 multiple myeloma patients

Hakan Kaya; Benjamin Peressini; Irfan Jawed; Danko Martincic; Ameer L. Elaimy; Wayne T. Lamoreaux; Robert K. Fairbanks; Kevin A. Weeks; Christopher M. Lee

Blood | 2013

Randomized Placebo-Controlled Phase III Study Of Perifosine Combined With Bortezomib and Dexamethasone In Relapsed, Refractory Multiple Myeloma Patients Previously Treated With Bortezomib

Arnon Nagler; Dina Ben-Yehuda; Ashraf Badros; Parameswaran Hari; Roman Hájek; Ivan Spicka; Hakan Kaya; Richard Le Blanc; Sung-Soo Yoon; Kihyun Kim; Joaquin Martinez-Lopez; Moshe Mittelman; Ofer Shpilberg; Elena Tóthová; Jacob P. Laubach; Irene M. Ghobrial; Merav Leiba; Moshe E. Gatt; Peter Sportelli; Michael Chen; Kenneth C. Anderson

Blood | 2016

Pomalidomide + Low-Dose Dexamethasone Following Second-Line Lenalidomide-Based Therapy in Relapsed or Refractory Multiple Myeloma: A Phase 2 Study Investigating Efficacy and Safety

David Siegel; Gary J. Schiller; Kevin W. Song; Richy Agajanian; Keith Stockerl-Goldstein; Hakan Kaya; Michael Sebag; Fred Reu; Ehsan Malek; Jorge Mouro; Weiyuan Chung; Shankar Srinivasan; Max Qian; Syed Rizvi; Anjan Thakurta; Nizar J. Bahlis

Blood | 2013

A New Multinational Observational Study In Multiple Myeloma: Initial Report Of The PREAMBLE Study

Mehdi M. Moezi; Robin Foà; Gordon Cook; Antonio Palumbo; Hakan Kaya; Brian G. M. Durie; David Cella; Lieven Annemans; Yun Su; Pralay Mukhopadhyay; Trong Kim Le; Maria Teresa Petrucci

World Journal of Oncology | 2012

A Review of Novel Systemic Therapies and Brain Radiosurgery for Metastatic Melanoma

Dexter A Overbay; Hakan Kaya; Wayne T. Lamoreaux; Robert K. Fairbanks; Alexander R. Mackay; John J. Demakas; Barton S Cook; Christopher M. Lee

Journal of Clinical Oncology | 2017

MM-014: A phase 2 trial evaluating efficacy, safety, and biomarkers of pomalidomide plus low-dose dexamethasone (POM + LoDEX) in relapsed/refractory multiple myeloma (RRMM) following second-line lenalidomide plus dexamethasone (LEN + DEX).

David Siegel; Richy Agajanian; Rakesh Gaur; Kasra Karamlou; Hakan Kaya; Michael Sturniolo; Rosanna J. Ricafort; Gail Larkins; Shankar Srinivasan; Rajesh Chopra; Anjan Thakurta; Yasir Nagarwala; Flavio Kruter

Journal of Clinical Oncology | 2017

Pomalidomide (POM) + low-dose dexamethasone (LoDEX) after lenalidomide (LEN)-based second-line (2L) treatment (Tx) in patients (Pts) with relapsed/refractory multiple myeloma (RRMM): Analysis of progression-free survival (PFS) by level of disease control.

David Siegel; Gary J. Schiller; Kevin W. Song; Richy Agajanian; Keith Stockerl-Goldstein; Hakan Kaya; Michael Sebag; Frederic J. Reu; Ehsan Malek; Giampaolo Talamo; Jorge Mouro; Weiyuan Chung; Shankar Srinivasan; Max Qian; Syed Rizvi; Anjan Thakurta; Nizar J. Bahlis

Clinical Lymphoma, Myeloma & Leukemia | 2017

Phase 2 Study of Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) Following Second-Line Lenalidomide (LEN)-Based Treatment (Tx) in Patients (Pts) With Relapsed or Refractory Multiple Myeloma (RRMM): An Updated Analysis of Efficacy and Safety

David Siegel; Gary J. Schiller; Kevin W. Song; Richy Agajanian; Keith Stockerl-Goldstein; Hakan Kaya; Michael Sebag; Frederic J. Reu; Eshan Malek; Jorge Mouro; Weiyuan Chung; Shankar Srinivasan; Max Qian; Syed Rizvi; Anjan Thakurta; Nizar J. Bahlis

Blood | 2017

Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) Safety and Efficacy in Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM) Previously Treated with a Proteasome Inhibitor (PI) and in Whom Last Prior Therapy with Lenalidomide (LEN) Failed

David Siegel; Gary J. Schiller; Kevin W. Song; Richy Agajanian; Ketih Stockerl-Goldstein; Hakan Kaya; Michael Sebag; Christy Samaras; Ehsan Malek; Giampaolo Talamo; Christopher S. Seet; Jorge Mouro; Faiza Zafar; Weiyuan Chung; Shankar Srinivasan; Max Qian; Amit Agarwal; Anjan Thakurta; Nizar J. Bahlis

Blood | 2015

Investigating Efficacy, Safety, and Biomarkers in a Phase 2 Trial of Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) Following Second-Line Lenalidomide-Based Therapy (Tx) in Relapsed or Refractory Multiple Myeloma (RRMM)

David Siegel; Gary J. Schiller; Kevin W. Song; Richy Agajanian; Keith Stockerl-Goldstein; Hakan Kaya; Michael Sebag; Frederic J. Reu; Jorge Mouro; Michael Sturniolo; Shankar Srinivasan; Anjan Thakurta; Yasir Nagarwala; Nizar J. Bahlis

Explore More

Collaboration

Dive into the Hakan Kaya's collaboration.

Top Co-Authors
Avatar

Anjan Thakurta

Celgene

View shared research outputs
Top Co-Authors
Avatar

David Siegel

Hackensack University Medical Center

View shared research outputs
Top Co-Authors
Avatar

Shankar Srinivasan

Celgene

View shared research outputs
Top Co-Authors
Avatar

Gary J. Schiller

University of California

View shared research outputs
Top Co-Authors
Avatar

Jorge Mouro

Celgene

View shared research outputs
Top Co-Authors
Avatar

Kevin W. Song

Vancouver General Hospital

View shared research outputs
Top Co-Authors
Avatar

Michael Sebag

McGill University

View shared research outputs
Top Co-Authors
Avatar

Nizar J. Bahlis

University of Calgary

View shared research outputs
Top Co-Authors
Avatar

Christopher M. Lee

University of Utah

View shared research outputs
Top Co-Authors
Avatar

Keith Stockerl-Goldstein

Washington University in St. Louis

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge